- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 108.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 107.6M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.61M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.24M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.99M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$23.07M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $24.96M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $24.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$60.12M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$29.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $93.21M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $101.52M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $332.13M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $325.93M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $115.58M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $136.72M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $271.99M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $296.26M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $18.03M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $14.49M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.45M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.45M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$30.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$19.14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$16.84M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$14.48M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $35.2M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $41.05M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $60.54M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $63.13M |
| Revenue | Q1 2026 · Mar 31, 2026 | $95.73M |
| Revenue | Q1 2026 · Mar 31, 2025 | $104.17M |